ABSTRACT
INTRODUCTION
Measurement of respiratory muscle strength is clinically useful in the assessment of selected patients, most commonly those with neuromuscular diseases or unexplained breathlessness. [1, 2] Maximum inspiratory (PImax) and expiratory (PEmax) pressures are most frequently measured. PImax and PEmax are simply and quick tests and high values exclude clinically significant weakness. However, low values are common and may reflect poor technique or effort, rather than muscle weakness. [3] Additional tests are available which are likely to improve diagnostic precision but are more complex and invasive. [4] [5] [6] [7] [8] We have reviewed our test results, in patients referred for assessment of respiratory muscle strength, to determine the value of multiple respiratory muscle tests. We hypothesized that multiple tests might reduce the number of patients erroneously diagnosed as having weakness.
PATIENTS AND METHODS
Test results of clinical referrals made to the respiratory muscle laboratories of King´s College and Brompton Hospitals between 2000-2006 were analysed. Tests were undertaken according to established methods, as described in the ATS/ERS joint statement. [3] The tests were:
1) PImax
Maximum inspiratory pressures were measured from functional residual capacity in the standard way, [3, 9] with the patient seated, wearing a nose-clip and using a flanged mouthpiece (P.K. Morgan Ltd ® , Rainham, UK). Repeated efforts were made, until consistent results were achieved, and the numerically largest pressure noted. The average of the pressure was measured over one second. [3] Several publications report normal values using a flanged mouthpiece. [9] [10] [11] [12] Weakness was defined as the mean normal value minus 1.96 standard deviations based on the study by Wilson et al (Table 1) . [9] This number reflect the 100%-line in the figures in the results section. 
Test

2) Sniff manoeuvers
Balloon catheters for the measurement of pressure (Cooper Surgical  , CT/USA) lubricated with lignocaine (2%) gel, were introduced via one nostril into the oesophagus and stomach as described by Baydur et al. [13] The distal balloon (filled with 2ml of air) measured the gastric pressure (Pgas); the proximal balloon (filled with 0.5ml of air) the oesophageal pressure (Poes (Table 1) . [6] No distinction was made for normal values between the sexes because the available literature on gender differences is insufficient.
4) PEmax
Maximum expiratory pressures were measured from total lung capacity in the standard way, with the patient seated, wearing a nose-clip and using a flanged mouthpiece (P.K.
Morgan Ltd ® , Rainham, UK). [3, 9] Repeated efforts were made, until consistent results were achieved; the numerically largest pressure averaged over one second was measured. [3] Several studies have reported normal values, using a flanged mouthpiece. [9] [10] [11] [12] Normal value cutoffs refer to the study of Wilson et al (Table 1 ). [9] 
5) Cough gastric pressure (Cough Pgas)
Pressure balloons were positioned as described in section 2. The cough manoeuver was performed as previously reported, breathing in deeply first, with the patient seated, wearing a nose-clip. [3] Coughs were repeated at least 5-10 times, until consistent measurements were achieved. The numerically highest value was taken, measuring from relaxed end-expiratory baseline gastric pressure to peak pressure during the cough. Man et al described cough gastric pressures in 99 healthy volunteers, enabling normal cutoffs to be calculated (Table 1) . [7] 6) Twitch T10 gastric pressure (Twitch T10) Gastric pressure was measured as described in section 2 and magnetic stimulation of the thoracic nerve roots was performed with a 90mm circular coil (P/N9784-00; MAGSTIM Company Ltd.
 , Whitland, UK) placed with its centre over the 10 th thoracic vertebra in the mid-line. [16] The manoeuver was undertaken at functional residual capacity, with the patient seated, wearing a nose-clip, and the mouth closed.
Twitches were repeated at least 5-10 times, until consistent measurements were obtained, and an average Twitch T10 was calculated. There are few normal data reported for this test. Our laboratory data is from 65 normal subjects (41 males, 24 females, mean age 51 (16) ) to give the cutoff in Table 1 . As for Twitch Pdi, no distinction was made between sexes due to the relatively limited data.
The outcome of the respiratory muscle tests, in diagnosing weakness was studied, singly and in combination. Cross-tabulation identified the diagnosis of weakness for each test, and the added value of using more than one test in detecting respiratory muscle weakness was determined.
For the purposes of analysis, patients` data were used for comparison only if all of the global inspiratory, specific diaphragm, or expiratory muscle tests were performed. For inspiratory muscle tests (PImax, Sniff Pnasal and Sniff Poes) this was 182 of the referrals (Group A), for diaphragm specific tests (Sniff Pdi and Twitch Pdi) 264 (Group B), and for expiratory muscle tests (PEmax, Cough Pgas and Twitch T10) 60 (Group C). Individual test results were judged relative to the diagnosis achieved by combining all relevant tests.
For statistical analysis and graph-plots, we used SPSS  Version 13.0 (SPSS  Inc., Chicago, IL, USA). Results are given as mean (standard deviation, SD) for all tests except Twitch T10 values, for which results are given as median and interquartile range because of non-normal distribution of the data. Correlation coefficients were calculated for all tests (Pearson´s correlation coefficient), except Twitch T10, for which Spearman´s correlation coefficient was used. Values for single tests were converted into percentage of cutoff-threshold for males and females as described above. Weakness was defined as a result of <100% of the cutoff threshold, while normal strength was considered as being ≥100% of this value. To describe and compare the test combinations we calculated the mean of the different populations, the standard error of the mean (SEM), and the 95% confidence interval (CI). Significance was accepted at the level of 95%.
RESULTS
The most common reason for referral was to investigate neuromuscular diseases and the cause of breathlessness (Tables 2 and 3 ). For the 3 groups data on age, sex, and lung function are shown in Table 4 ; results of respiratory muscle tests are shown in Table 5 Figure 1 ), between PImax and Sniff Poes was r=0.73 (p<0.01; Figure 1 ), and Sniff Pnasal vs Sniff Poes was r=0.90 (p<0.01; Figure 1) . The cross-tabulation (Table 6 ) shows the numbers of the patients having low or normal results in all of the tests. Combining the results for the three tests of global inspiratory muscle strength demonstrated a diagnosis of weakness in 29.1% (Table 7) . This is a relative reduction of 27.4% compared to PImax alone. Using two non-invasive tests, PImax and Sniff Pnasal, in combination obtained a similar result (low in 32.4%). 
Cross-tabulation for Group
Diaphragm Strength Tests (Group B)
For tests of diaphragm function the 264 clinical referrals who had both Sniff Pdi and Twitch Pdi measurements were analysed (Table 5 ). 68.2% had weakness when assessed by Sniff Pdi, and 67.4% when Twitch Pdi was measured. Correlation between Sniff Pdi and Twitch Pdi was r=0.57 (p<0.01; Figure 2 ). Combining both tests reduced the number of patients considered to have diaphragm weakness to 55.3% (Tables 6 and 8 
Expiratory Muscle Tests (Group C)
For expiratory muscle strength tests, data of 60 patients who completed measurement of cough Pgas, Twitch T10 as well as PEmax were analysed. 38.3% of the patients had expiratory muscle weakness when assessed by PEmax. When assessed by cough Pgas 36.7% of the patients had low values, and with Twitch T10, 28.3% of the patients were considered to be weak. The correlation between PEmax and cough Pgas was r=0.61 (p<0.01; Figure 3) , between PEmax and Twitch T10 r=0.28 (p=0.03; Figure 3) , and between cough Pgas and Twitch T10 r=0.63 (p<0.01; Figure 3) . The combination of all three tests of expiratory muscle strength yielded a diagnosis of weakness in 16.7% (Table 6 and Table 9 : SEM = Standard Error of the Mean, CI = Confidence Interval. The combination of PEmax, cough Pgas and Twitch T10 diagnosed 16.7% of the patients to have expiratory muscle weakness, and reduced the number of falsely positive diagnoses compared to PEmax and Cough Pgas. The relative reduction of false diagnosis was 56.4% compared to PEmax, and 54.5% compared to cough Pgas. DISCUSSION PImax and PEmax are widely used, easily applied and non-invasive bedside tests. In our study PImax and PEmax diagnosed weakness in 40.1% and 38.2% respectively. However, the tests require maximal effort, coordination and cooperation and low values are common and difficult to interpret with confidence. [3, 4] Sniff Pnasal achieves similar results as PImax and Sniff Poes, whilst more precise, is invasive. Sniff Poes, compared to Sniff Pnasal, reduces the diagnosis of weakness by about 10%. The combination of the two non-invasive tests, PImax and Sniff Pnasal, reduces the diagnosis of weakness by about 20% compared to Sniff Pnasal or PImax alone. It is of interest that by performing all three tests the increase in diagnostic precision is around 30% compared to PImax or Sniff Pnasal alone, but they are not significantly better than the combination of PImax and Sniff Pnasal. Thus, for patients who are able to sniff, and in whom there is likely to be good transmission of intrathoracic pressures (there being no nasal obstruction or airways obstruction) the combination of the non-invasive tests PImax and Sniff Pnasal is almost as precise as when the invasive Sniff Poes test is added to the assessment.
In this study cough Pgas and PEmax resulted in similar diagnostic outcomes, but the combination of these two volitional tests reduced the diagnosis of expiratory muscle weakness by around 30% compared to PEmax. The combination of all three expiratory tests reduced the diagnosis of weakness by approximately 55% and was the only combination that reached statistical significance in comparison to the single tests PEmax and cough Pgas.
For the diaphragm specific tests, 68.2% of the referrals were weak when assessed by Sniff Pdi and 67.4% by Twitch Pdi. Tests of diaphragm function are complex and relatively invasive. For patients able to perform maximum sniff efforts the Sniff Pdi test is as precise as Twitch Pdi, and less costly. However, there will be clinical situations in which Twitch Pdi is more appropriate, as when assessing patients in ICU, and the Twitch technique also allows the separate evaluation of each hemidiaphragm. Furthermore, the combination of Sniff Pdi and Twitch Pdi is more precise then either test alone, reducing the relative risk of a false diagnosis of weakness by almost 20%.
The validity of cut-off values is important. Tests of respiratory muscle strength can either show normal or low results. A low test result means that the patient is weak as judged by this single test. The different cut-off points for each test were taken from the appropriate literature. We compared the published data most appropriate to the methods used at King´s College Hospital and Royal Brompton Hospital. The cut-off for a normally distributed population was taken for all tests (except the non-normally distributed Twitch T10) by subtracting 1.96xStandard Deviation from the mean for a normal population. This definition is widely accepted for creating cut-offs and defining "abnormality". We adopted a similar approach for all tests, except Twitch T10 for which the only data are our own laboratory values. The number of normal subjects, for each test, reported in the literature is substantial, and reproducibility well described, although we acknowledge that future studies of Twitch T10, to supplement our own results from 65 normal subjects, will be useful.
A limitation of the study is a lack of sufficient normal data on the nonvolitional tests that were used to assess diaphragm strength (Twitch Pdi) and expiratory muscle strength (Twitch T10), which does not allow a distinction between reference values for different sexes. More data, from future studies, are needed for Twitch Pdi and Twitch T10 to establish normal values for males and females. Inevitably, combining male and female data must reduce the sensitivity of the tests for diagnosing weakness. The relative paucity of Twitch T10 data reduces but does not negate the considerable value of Twitch T10 as an expiratory muscle test. Combining Twitch T10 results with other, voluntary, tests is helpful in so much as some patients are less good at voluntary tests, but will reduce sensitivity in so much as the Twitch T10 test has inherent variability, including that due to gender. Despite the fact that lack of gender specific data for Twitch T10 must reduce the sensitivity of the test it is of note that the test diagnoses weakness in a slightly higher percentage of cases than the PEmax + Cough Pgas combination.
In summary, the outcome of any one test of inspiratory, specific diaphragm, or expiratory muscle strength is broadly similar to any other test. However, combination of tests can substantially increase diagnostic precision. In many patients it is the assessment of inspiratory muscle strength that is most clinically relevant and the good diagnostic performance of the non-invasive PImax -Sniff Pnasal combination is important.
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